Edition:
United Kingdom

Merck KGaA (MRCG.DE)

MRCG.DE on Xetra

96.10EUR
11:06am GMT
Change (% chg)

€0.50 (+0.52%)
Prev Close
€95.60
Open
€96.14
Day's High
€96.58
Day's Low
€95.48
Volume
97,210
Avg. Vol
559,951
52-wk High
€100.20
52-wk Low
€74.54

Select another date:

Tue, Nov 20 2018

Photo

Palantir to offer cancer analytics under JV deal with Germany's Merck

((This NOV 19 story corrects to show Merck is Palantir's exclusive partner within the JV, not for all of Palantir's healthcare activities, paragraph 11))

CORRECTED-UPDATE 1-Palantir to offer cancer analytics under JV deal with Germany's Merck

FRANKFURT, Nov 19 Palantir Technologies Inc will set up a cancer data analytics joint venture with German lab supplies company Merck KGaA, as the U.S. analytics and security firm makes further inroads into health care.

Palantir to offer cancer analytics under JV deal with Germany's Merck

FRANKFURT, Nov 19 Palantir Technologies Inc will set up an exclusive cancer research joint venture with German lab supplies company Merck KGaA, as the U.S. data analytics and security firm makes further inroads into health care.

Merck KGaA third-quarter earnings down on weak Latam currencies

FRANKFURT German drugs and lab supplies maker Merck KGaA saw adjusted core earnings decline and lowered its full-year profit outlook as a decline in Latin American currencies weighed on the value of overseas sales.

Merck KGaA Q3 earnings down on weak Latam currencies

FRANKFURT, Nov 14 German drugs and lab supplies maker Merck KGaA saw adjusted core earnings decline and lowered its full-year profit outlook as a decline in Latin American currencies weighed on the value of overseas sales.

Merck KGaA says might strike partnership deal this year

MUNICH German drugmaker Merck KGaA might agree partnership deals to jointly develop two of its most promising experimental medicines with a rival as early as this year, but more likely in 2019, its drug research and development chief said on Sunday.

Merck KGaA says might strike partnership deal this year

MUNICH, Oct 21 German drugmaker Merck KGaA might agree partnership deals to jointly develop two of its most promising experimental medicines with a rival as early as this year, but more likely in 2019, its drug research and development chief said on Sunday.

EU clears 3.4 billion euro P&G deal for German Merck's consumer health business unit

BRUSSELS EU antitrust regulators have approved Procter & Gamble's (P&G) 3.4 billion euro (£3.08 billion) acquisition of Merck KGaA's consumer health unit, saying on Tuesday that they had no competition concerns.

EU clears $3.9 billion P&G deal for German Merck's consumer health business unit

BRUSSELS EU antitrust regulators have approved Procter & Gamble's (P&G) 3.4 billion euro ($3.9 billion) acquisition of Merck KGaA's consumer health unit, saying on Tuesday that they had no competition concerns.

EU clears $3.9 bln P&G deal for German Merck's consumer health business unit

BRUSSELS, Aug 28 EU antitrust regulators have approved Procter & Gamble's (P&G) 3.4 billion euro ($3.9 billion) acquisition of Merck KGaA's consumer health unit, saying on Tuesday that they had no competition concerns.

Select another date: